Diabetes Devices Market (Product Type: Glucose Monitoring Devices, Insulin Delivery Devices, Diabetes Management Software, and Artificial Pancreas System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Report Highlights
Diabetes Devices Market – Scope of Report
TMR’s report on global diabetes devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global diabetes devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global diabetes devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the diabetes devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global diabetes devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global diabetes devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global diabetes devices market.
The report delves into the competitive landscape of the global diabetes devices market. Key players operating in the global diabetes devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global diabetes devices market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market diabetes devices.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
- Company websites, presentations, annual reports, white papers, technical paper, product brochure
- Internal and external proprietary databases and relevant patents
- National government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
- Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
- Helps in validating and strengthening secondary research findings
- Further develops the analysis team’s expertise and market understanding
- Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
- Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
- Purchasing/Sourcing managers, technical personnel, distributors
- Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
- Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
- Advanced Oncotherapy PLC
- Danfysik A/S
- Hitachi, Ltd.
- IBA Worldwide
- Mevion Medical Systems, Inc.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2022 |
| Forecast period considered | 2022-2031 |
| Growth rate | 6.00% |
| Units considered | $ Million |
| Segments covered | By Product Type, By Distribution Channel, By Region |
| Industry covered | Healthcare |
| Countries covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America |
| Companies studied |
|
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
- Table 1 : Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product type, 2017–2031
- Table 2 : Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Glucose Monitoring Devices 2017–2031
- Table 3 : Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2017–2031
- Table 4 : Global Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 5 : Global Insulin Delivery Devices Market Size (US$ Mn) Forecast, by Region, 2017–2031
- Table 6 : North America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017–2031
- Table 7 : North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
- Table 8 : North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Glucose Monitoring Devices 2017–2031
- Table 9 : North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2017–2031
- Table 10 : North America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 11 : Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 12 : Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
- Table 13 : Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Glucose Monitoring Devices, 2017–2031
- Table 14 : Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2017–2031
- Table 15 : Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 16 : Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 17 : Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
- Table 18 : Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2031
- Table 19 : Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2031
- Table 20 : Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 21 : Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 22 : Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
- Table 23 : Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2031
- Table 24 : Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2031
- Table 25 : Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 26 : Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 27 : Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
- Table 28 : Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2031
- Table 29 : Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2031
- Table 30 : Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Figure 1 : Global Diabetes Devices Market, by Product, Market Size (US$ Mn), 2021 (A)
- Figure 2 : Global Diabetes Devices Market, by Distribution Channel, Market Share, 2021 (A)
- Figure 3 : Global Diabetes Devices Market Size (US$ Mn) Forecast, 2017–2031
- Figure 4 : Company Revenue Share (1)
- Figure 5 : Company Revenue Share (2)
- Figure 6 : Estimated Number of People with Diabetes Worldwide and Per Region (Age 20-79 years)
- Figure 7 : Global Diabetes Devices Market Value Share, by Product Type, 2021 and 2025
- Figure 8 : Global Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031
- Figure 9 : Global Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
- Figure 10 : Global America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2021 and 2031
- Figure 11 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Glucose Monitoring Devices, 2017–2031
- Figure 12 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Insulin Delivery Devices, 2017–2031
- Figure 13 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Monitoring Software, 2017–2031
- Figure 14 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Pancreas System, 2017–2031
- Figure 15 : Global Diabetes Devices Market Value Share, by Distribution Channel, 2021 and 2025
- Figure 16 : Global Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 17 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2031
- Figure 18 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2031
- Figure 19 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2031
- Figure 20 : Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Clinics/ Centers, 2017–2031
- Figure 21 : Global Diabetes Device Market Scenario, by Country (1/1)
- Figure 22 : Global Diabetes Devices Market Value Share Analysis, by Region, 2021 and 2025
- Figure 23 : Global Diabetes Devices Market Attractiveness Analysis, by Region, 2022–2031
- Figure 24 : North America Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
- Figure 25 : North America Diabetes Devices Market Attractiveness Analysis, by Country, 2022–2031
- Figure 26 : North America Diabetes Devices Market Value Share Analysis, by Country, 2021 and 2031
- Figure 27 : North America Diabetes Devices Market Value Share, by Product Type, 2021 and 2031
- Figure 28 : North America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031
- Figure 29 : North America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
- Figure 30 : North America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2021 and 2031
- Figure 31 : North America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
- Figure 32 : North America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 33 : Europe Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
- Figure 34 : Europe Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 35 : Europe Diabetes Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 36 : Europe Diabetes Devices Market Value Share, by Product Type, 2021 and 2031
- Figure 37 : Europe Diabetes Devices Market Attractiveness Analysis, by Product Type, 2017–2031
- Figure 38 : Europe Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
- Figure 39 : Europe Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031
- Figure 40 : Europe Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
- Figure 41 : Europe Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 42 : Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017–2031
- Figure 43 : Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 44 : Asia Pacific Diabetes Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 45 : Asia Pacific Diabetes Devices Market Value Share Analysis, by Product Type, 2021 and 2031
- Figure 46 : Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031
- Figure 47 : Asia Pacific Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
- Figure 48 : Asia Pacific Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031
- Figure 49 : Asia Pacific Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
- Figure 50 : Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 51 : Latin America Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017–2031
- Figure 52 : Latin America Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 53 : Latin America Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 54 : Latin America Market Value Share Analysis, by Product Type, 2021 and 2031
- Figure 55 : Latin America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031
- Figure 56 : Latin America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
- Figure 57 : Latin America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031
- Figure 58 : Latin America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
- Figure 59 : Latin America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 60 : Middle East & Africa Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast 2017–2031
- Figure 61 : Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 62 : Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 63 : Middle East & Africa Market Value Share Analysis, by Product Type, 2022–2031
- Figure 64 : Middle Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031
- Figure 65 : Middle East & Africa Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
- Figure 66 : Middle East & Africa Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031
- Figure 67 : Middle East & Africa Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
- Figure 68 : Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 69 : Medtronic, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 70 : Medtronic, R&D Intensity and Sales & Marketing Intensity (%) – Company Level or Segment Level, 2017–2021
- Figure 71 : Medtronic, Breakdown of Net Sales, by Region 2017
- Figure 72 : Medtronic, Breakdown of Net Sales, by Business Segments, 2017
- Figure 73 : Novo Nordisk A/S, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 74 : Novo Nordisk A/S, R&D Intensity and Sales & Marketing Intensity (%), 2017–2021
- Figure 75 : Novo Nordisk A/S, Breakdown of Net Sales, by Region 2021
- Figure 76 : Novo Nordisk A/S, Breakdown of Net Sales, by Business Segments, 2021
- Figure 77 : Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 78 : Sanofi, R&D Intensity and Sales & Marketing Intensity (US$ Bn), 2017–2021
- Figure 79 : Sanofi, Breakdown of Net Sales, by Region 2021
- Figure 80 : Sanofi, Breakdown of Net Sales, by Business Segments, 2021
- Figure 81 : Eli Lilly and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 82 : Eli Lilly and Company, R&D Intensity and Sales & Marketing Intensity – Company Level, 2017–2021
- Figure 83 : Eli Lilly and Company, Breakdown of Net Sales, by Region 2017
- Figure 84 : Eli Lilly and Company, Breakdown of Net Sales, by Endocrinology Segment, 2021
- Figure 85 : F. Hoffmann-La Roche Ltd., Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 86 : F. Hoffmann-La Roche Ltd., R&D Intensity (US$ Bn), 2017–2021
- Figure 87 : F. Hoffmann-La Roche Ltd., Breakdown of Net Sales of Diabetes Care Business Area, by Region 2021
- Figure 88 : F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Diagnostic Division, 2021
- Figure 89 : Becton, Dickinson and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 90 : Becton, Dickinson and Company, R&D Expense (US$ Mn), 2017–2021
- Figure 91 : Becton, Dickinson and Company, Breakdown of Net Sales, by Region 2021
- Figure 92 : Becton, Dickinson and Company, Breakdown of Net Sales, by BD Medical Business segment, 2021
- Figure 93 : Tandem Diabetes Care, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021
- Figure 94 : Tandem Diabetes Care, Inc., R&D Expense (US$ Mn), 2017–2021
- Figure 95 : Abbott Laboratories, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 96 : Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity – Company Level, 2017–2021
- Figure 97 : Abbott Laboratories, Breakdown of Net Sales, by Region 2021
- Figure 98 : Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2021
- Figure 99 : Cellnovo, Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021
- Figure 100 : Insulet Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021
- Figure 101 : Insulet Corporation, R&D Intensity and Sales & Marketing Intensity (US$ Mn) – Company Level, 2017–2021
- Figure 102 : Insulet Corporation, Breakdown of Net Sales, by Region, 2021
- Figure 103 : Insulet Corporation, Breakdown of Net Sales, by Business Segments 2021
- Figure 104 : LifeScan, Inc., Concerned Company Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
- Figure 105 : LifeScan, Inc., R&D Intensity and Sales & Marketing Intensity – Company Level, 2017–2021
- Figure 106 : LifeScan, Inc., Breakdown of Net Sales, by Region (Company Level), 2021
- Figure 107 : LifeScan, Inc., Breakdown of Net Sales, (By Business And Business Segment Level), 2021
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.